Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBS Nebraska intranasal ablation Prior Auth | Ope…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - NebraskaPolicy M.48

    Intranasal Cryoablation or Radiofrequency Ablation for Rhinitis (Preauthorization Required)

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Nebraska Policy M.48 alerts

    Get alerted when Policy M.48 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This medical policy governs coverage and preauthorization requirements for intranasal cryoablation, radiofrequency ablation, and laser ablation procedures targeting the posterior nasal nerve for treatment of chronic rhinitis for Blue Cross Blue Shield - Nebraska members.

    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyIntranasal Cryoablation or Radiofrequency Ablation for Rhinitis (Preauthorization Required)
    Policy CodePolicy M.48
    Change TypeNo material change
    Effective DateMay 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNov 4, 2026
    Key ActionObtain prior authorization before performing intranasal cryoablation, radiofrequency ablation, or laser ablation for chronic rhinitis.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Procedural categories
    3CPT codes listed
    05-01-2026Original effective date
    © 2026Policy year

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ≥1RCTs referenced

    Coverage Determination and Rationale

    Overall coverage determination

    Covered when ALL of the following are met:

    Policy determination: Cryoablation, radiofrequency ablation, and laser ablation targeting the posterior nasal nerve for treatment of chronic rhinitis (allergic or nonallergic) are considered not reasonable and necessary because effectiveness has not been established.

    Insufficient evidence: limitations of available randomized trials include unclear enrollment of patients refractory to medical management; single-arm studies lack comparators and have high risk of bias and loss to follow-up.

    The following procedures are not reasonable and necessary for the treatment of chronic rhinitis because effectiveness has not been established: intranasal cryoablation, radiofrequency ablation, and laser ablation targeting the posterior nasal nerve. Claims for these procedures are therefore considered not covered under this policy.

    Specifically, intranasal cryoablation (e.g., ClariFix), radiofrequency ablation (e.g., RhinAer), and laser ablation for chronic rhinitis (allergic or nonallergic) are determined to be not reasonable and necessary due to insufficient evidence demonstrating clinical effectiveness.

    These Medical Policies are developed by the BCBSN Medical Policy Committee to determine the scientific validity of technologies and treatments and are used in administering plan benefits. They do not constitute medical advice, nor do they serve as authorization, certification, or a contract for benefits. Providers are responsible for clinical care decisions and must follow the terms of the applicable benefit contract for coverage determinations.

    Procedure and Reference Codes

    Procedure CPT codes listed in policyCPT
    30117EXCISION OR DESTRUCTION (EG, LASER), INTRANASAL LESION; INTERNAL APPROACH
    30999UNLISTED PROCEDURE, NOSE
    31242Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve
    31243Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve
    31299Unlisted procedure, accessory sinuses
    CPT (referenced)CPT
    CPTThis policy references CPT codes; specific codes are referenced elsewhere in the full policy text.

    Prior Authorization, Documentation, and Operational Guidance

    Prior Authorization

    Prior authorization required — procedures considered not reasonable and necessary

    Preauthorization is required for intranasal cryoablation, radiofrequency ablation, and laser ablation for chronic rhinitis; these procedures are considered not reasonable and necessary because effectiveness has not been established and claims for these procedures risk denial.

    • Referenced procedure codes include: 30117, 30999, 31242, 31243, 31299.
    Prior Authorization

    Preauthorization Required — obtain authorization per benefit contract

    This Medical Policy header states 'Preauthorization Required'; providers must obtain prior authorization per the member's benefit contract before scheduling these procedures.

    • Benefits for a particular service are determined by the terms and conditions of the applicable benefit contract.

    Clinical Background

    Chronic rhinitis is a common condition that includes allergic, nonallergic, and mixed forms and can substantially impair quality of life through symptoms such as nasal congestion, rhinorrhea, sneezing, and postnasal drip. First-line management is medical therapy (for example, topical nasal corticosteroids, topical anticholinergics, nasal decongestants, and oral or intranasal antihistamines). For patients who remain symptomatic despite adequate medical management (often referenced in studies as at least several weeks to months of therapy), procedural options targeting the posterior nasal nerve — historically including vidian neurectomy and more recently minimally invasive approaches such as cryoablation, radiofrequency ablation, or laser ablation — have been developed to reduce parasympathetic-driven nasal secretions and mucosal blood flow.

    Key Definitions

    Refractory chronic rhinitis — definition and medical therapy durations
    DefinitionChronic rhinitis not adequately controlled after adequate medical therapy (referred to as refractory chronic rhinitis).
    First-line medical management therapiesTopical nasal steroids, anticholinergics, nasal decongestants, and antihistamines (used before considering invasive interventions).
    Clinical implicationRefractory designation is required to justify consideration of invasive posterior nasal nerve–targeting procedures.
    Posterior nasal nerve ablation — intervention targeting posterior nasal nerve branches
    DefinitionIntervention (surgical or minimally invasive) targeting branches of the posterior nasal nerve to interrupt parasympathetic stimulation of the nasal mucosa, reducing glandular secretions and blood flow.
    Examples of approaches
    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyIntranasal Cryoablation or Radiofrequency Ablation for Rhinitis (Preauthorization Required)
    Policy CodePolicy M.48
    Change TypeNo material change
    Effective DateMay 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNov 4, 2026
    Key ActionObtain prior authorization before performing intranasal cryoablation, radiofrequency ablation, or laser ablation for chronic rhinitis.
    SourceLink
    On This Page
    Coverage Determination and RationaleProcedure and Reference CodesPrior Authorization, Documentation, and Operational GuidanceClinical BackgroundKey Definitions
    Step Therapy

    Attempt adequate medical therapy before procedural interventions

    Initial treatment for chronic rhinitis is medical management; invasive interventions should be considered only for patients who do not improve after adequate medical therapy.

    • Medical management may include topical steroids, anticholinergics, nasal decongestants, and antihistamines.
    • Refractory chronic rhinitis refers to symptoms not controlled after adequate medical therapy (examples in cited studies include minimum 4 weeks of topical nasal steroid or failure after at least 3 months of medical therapy).
    Documentation Required

    Suggested documentation — indicate chronic rhinitis and refractory status

    Document the indication as chronic rhinitis and provide supporting evidence that the patient was refractory to adequate medical therapy when using procedural justification.

    • Include prior treatments and durations (e.g., topical nasal steroid for ≥4 weeks or failure after ≥3 months of medical therapy) when applicable.
    • If citing study-based definitions of refractory, note the criteria used in those studies.
    Documentation Required

    Documentation expectations — Committee review and provider responsibility

    The Medical Policy Committee reviews scientific publications to develop policies, but providers remain responsible for medical advice and treatment decisions for individual patients.

    • Policies are used in administering plan benefits and are subject to change; they do not replace clinical judgment.
    Denial Risk

    Denial risk — procedures considered not reasonable and necessary

    Claims for intranasal cryoablation, radiofrequency ablation, and laser ablation risk denial because these procedures are determined to be not reasonable and necessary due to insufficient evidence of efficacy.

    • The policy conclusion: these procedures are considered not reasonable and necessary because effectiveness has not been established.
    Note

    Policy does not equal authorization or guarantee of benefits

    Medical Policies do not constitute authorization, certification, or a contract for benefits; confirmation of coverage and authorization must be obtained through the member's benefit contract and authorization processes.

    • Do not assume policy determination = coverage; verify benefits and obtain required authorizations separately.
    Documentation Required

    Provider action — obtain complete documentation and verify benefits

    When prior authorizations are requested, provide complete clinical documentation and note that absence of required documentation or medical necessity may result in denial.

    • Include member-specific benefit verification and any prior-treatment documentation supporting refractory status.
    • Be aware that the Committee found insufficient evidence for efficacy, which underlies likely denial.
    Surgical ablation of post-ganglionic posterior nasal nerve and minimally invasive cryotherapy, radiofrequency ablation, or laser ablation performed endoscopically.
    Physiologic rationaleEfficacy is thought to result from interruption of efferent parasympathetic stimulation leading to reduced submucosal gland secretions and blood flow.
    Clinical contextConsidered for patients with chronic rhinitis refractory to adequate medical therapy as alternatives to more extensive procedures like vidian neurectomy.
    Vidian neurectomy — referenced surgical option
    DefinitionVidian neurectomy is a historical surgical option that targets the vidian nerve to reduce symptoms of refractory rhinitis.
    Efficacy and complicationsShown to reduce rhinorrhea but associated with side effects including cheek and palate numbness and dry eyes (reported in roughly 35%–72% of cases).
    Reason for newer approachesMore targeted posterior nasal nerve interventions were developed to improve on vidian neurectomy complications such as xerophthalmia.
    Literature referencesVidian neurectomy and related evidence are discussed in systematic reviews and reviews cited in policy references (e.g., Marshak 2016; Halderman & Sindwani 2015; StatPearls entry).